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Abstract
Nucleic acids are potent triggers for innate immunity. Double-
stranded DNA and RNA adopt different helical conformations,
including the unusual Z-conformation. Z-DNA/RNA is recognised by
Z-binding domains (ZBDs), which are present in proteins impli-
cated in antiviral immunity. These include ZBP1 (also known as DAI
or DLM-1), which induces necroptosis, an inflammatory form of cell
death. Using reconstitution and knock-in models, we report that
mutation of key amino acids involved in Z-DNA/RNA binding in
ZBP1’s ZBDs prevented necroptosis upon infection with mouse
cytomegalovirus. Induction of cell death was cell autonomous and
required RNA synthesis but not viral DNA replication. Accordingly,
ZBP1 directly bound to RNA via its ZBDs. Intact ZBP1-ZBDs were
also required for necroptosis triggered by ectopic expression of ZBP1
and caspase blockade, and ZBP1 cross-linked to endogenous RNA.
These observations show that Z-RNA may constitute a molecular
pattern that induces inflammatory cell death upon sensing by ZBP1.
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Introduction
Nucleic acids form double-stranded helices. Double-stranded (ds) DNA
typically adopts the so-called B-conformation, while dsRNA is usually
in the A-conformation. Both DNA and RNA can also adopt a Z-form
double helix that is characterised by a left-handed helical arrangement,
a zigzag pattern of the phosphodiester backbone and the absence of
major grooves (Wang et al, 1979; Hall et al, 1984; Rich & Zhang,
2003). Antibodies raised against Z-form RNA or DNA stain mammalian
cells and chromosomes, respectively, suggesting that nucleic acids in
this unusual conformation occur naturally in cells (Viegas-Péquignot
et al, 1983; Zarling et al, 1990). However, biological functions of the
Z-conformation are only partially understood (Rich & Zhang, 2003;
Wang & Vasquez, 2007). Z-DNA is believed to play a role in transcrip-
tion by relieving torsional strain induced within the DNA template by
the movement of RNA polymerases, and Z-DNA may also promote
genetic instability (Rich & Zhang, 2003; Wang & Vasquez, 2007).
Physiological functions of Z-RNA remain unknown.
Early biochemical and structural studies identified a protein fold
called Z-binding domain (ZBD) that specifically binds to Z-DNA but
not to B-DNA (Herbert et al, 1993; Schwartz et al, 1999). This 78-
amino-acid domain is also referred to as Za or Zb, and subsequent
work showed that it not only binds to Z-DNA but also to Z-RNA
(Brown et al, 2000; Placido et al, 2007). ZBDs have been identified
in four proteins: ADAR1, ZBP1, E3L and PKZ (Athanasiadis, 2012).
ADAR1 and ZBP1 are mammalian proteins implicated in antiviral
innate immune responses. E3L is a poxvirus protein known to
antagonise this host response. Lastly, PKZ is a fish protein related to
mammalian PKR, also involved in antiviral immunity. This suggests
an important role of ZBDs in innate antiviral immune responses
(Athanasiadis, 2012) and may imply that Z-DNA and/or Z-RNA trig-
ger such a host defence response. Z-form nucleic acids are further
implicated in immune responses by the observation that sera from
some systemic lupus erythematosus patients contain anti-Z-DNA
autoantibodies (Lafer et al, 1983).
Z-DNA binding protein 1 (ZBP1, also known as DAI or DLM-1)
has two N-terminal ZBDs (Za1 and Za2) and two RIP homotypic
interaction motifs (RHIMs) (Ha et al, 2008; Kaiser et al, 2008;
Rebsamen et al, 2009; Kim et al, 2011a,b; Yang et al, 2014). ZBP1
had initially been suggested to be a cytosolic B-DNA sensor that
induces type I interferons (IFNs) (Takaoka et al, 2007). However,
this observation could not be confirmed in ZBP1-deficient mice
(Ishii et al, 2008). Instead, ZBP1 activates NF-jB and triggers
necroptosis (Kaiser et al, 2008; Rebsamen et al, 2009; Upton et al,
2012), an inflammatory form of programmed cell death (Wallach
et al, 2016). NF-jB activation is mediated by RIPK1 and RIPK3
kinases, which bind to ZBP1 via RHIM-RHIM interactions (Kaiser
et al, 2008; Rebsamen et al, 2009). In contrast, ZBP1-dependent
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necroptosis depends on RIPK3 recruitment and does not require
RIPK1 (Upton et al, 2012). RIPK3 phosphorylates and activates the
pseudokinase MLKL, which upon oligomerisation ruptures the
plasma membrane, leading to cell death (Wallach et al, 2016).
Necroptosis mediates host defence by eliminating virus-infected
cells (Mocarski et al, 2015). Viruses in turn suppress necroptosis. A
well-studied example is mouse cytomegalovirus (MCMV) infection
(Mocarski et al, 2015): MCMV prevents ZBP1- and RIPK3-dependent
necroptosis by expression of M45 (Upton et al, 2010, 2012). M45
has a RHIM that disrupts the interaction of ZBP1 and RIPK3. MCMV
expressing M45 with a mutated RHIM fails to inhibit necroptosis,
resulting in death of infected cells (Upton et al, 2012). Necroptotic
cell death is normally held in check by the proteolytic activity of the
pro-apoptotic caspase-8. Cells can be sensitised to RIPK3-dependent
necroptosis by genetic loss (Kaiser et al, 2011; Oberst et al, 2011) or
chemical blockade of caspase-8 (Vandenabeele et al, 2006). During
M45-RHIM-mutant MCMV infection, the viral M36 protein—also
known as viral inhibitor of caspase-8-induced apoptosis (vICA)—is
believed to predispose cells to necroptosis by blocking caspase-8
(McCormick et al, 2003; Ménard et al, 2003; Guo et al, 2015).
Here, we show that necroptosis triggered by MCMV-M45mutRHIM
or by ectopic ZBP1 expression and caspase blockade required bind-
ing of nucleic acids to the tandem ZBDs of ZBP1. We generated
Zbp1 knock-in mice carrying four amino acid substitutions that
abrogate binding to Z-form nucleic acids. Cells from Zbp1-mutant
mice are resistant to MCMV-M45mutRHIM-induced necroptosis.
During infection, inhibition of RNA transcription but not of viral
DNA replication prevented ZBP1-dependent necroptosis and we
found that ZBP1 bound to newly synthesised RNA. Furthermore,
ZBP1 cross-linked to endogenous RNA and stained cells in an
RNase-sensitive manner. In sum, these results show that ZBP1 is an
RNA sensor.
Results
Cell death following MCMV-M45mutRHIM infection requires intact
ZBP1 ZBDs
We initially wished to confirm the role of ZBP1 in cell death upon
virus infection. Expression of ZBP1 was induced by IFN in Zbp1+/
but not in Zbp1/ primary mouse embryonic fibroblasts (MEFs;
Fig 1A). We then assessed cell viability upon virus infection by
determining intracellular ATP levels using CellTiter-Glo reagent.
Infection with MCMV-M45mutRHIM, a virus that fails to inhibit ZBP1-
RIPK3-dependent necroptosis (Upton et al, 2012), induced cell death
in Zbp1+/ primary MEFs following IFN pre-treatment (Fig 1B). In
contrast, viability upon MCMV-M45mutRHIM infection was much
higher in IFN-treated Zbp1/ primary MEFs (Fig 1B), despite
comparable expression of RIPK3 and MLKL (Fig 1A). We also
infected primary MEFs with MCMV-M45wt, which did not cause
much cell death in either Zbp1+/ or Zbp1/ cells (Fig 1B). As a
control, the induction of necroptosis by TNF stimulation in the pres-
ence of the caspase inhibitor zVAD (Vercammen et al, 1998) (here-
after simply TZ) was independent of ZBP1 (Fig 1B). Similar results
were obtained in immortalised MEFs (Fig EV1A and B). These
observations are consistent with an earlier report (Upton et al,
2012) and demonstrate that death of MCMV-infected cells required
ZBP1 and was antagonised by the viral M45 protein.
To test if binding of Z-form nucleic acids to ZBP1 is involved in
the induction of cell death during virus infection, we mutated key
conserved residues involved in Z-RNA/DNA binding in mouse
ZBP1. Based on the structures of the ZBP1 Za1 and Za2 domains
(Schwartz et al, 2001; Ha et al, 2008; Kim et al, 2011a,b; Yang et al,
2014) and on sequence alignments (Fig 1C and D), we introduced
N46A and Y50A mutations into Za1 (Za1mut), N122A and Y126A
substitutions into Za2 (Za2mut), and all four mutations together
(Za1a2mut). Mutation of the corresponding residues in ADAR1’s Za
ZBD completely abolishes Z-DNA binding without altering protein
stability (Schade et al, 1999); accordingly, we predicted diminished
binding of our ZBP1 mutants to Z-RNA/DNA. Wild-type and
Za1a2mut ZBP1 proteins were equally able to induce an NF-jB
reporter upon ectopic expression together with RIPK3 in HEK293T
cells, suggesting that the mutant protein folds correctly and retains
signalling via its RHIMs (Figs 1E and EV1C).
We reconstituted immortalised Zbp1/ MEFs with ZBP1
3xFLAG-tagged ZBD mutants (Fig 1F). Cell viability following TZ
treatment or MCMV-M45wt infection was comparable between
parental Zbp1/ and ZBP1-reconstituted cells (Fig 1G). MCMV-
M45mutRHIM infection induced pronounced cell death in ZBP1 wild-
type reconstituted cells (Fig 1G and H). In contrast, ZBP1-Za1a2mut-
expressing cells displayed higher viability after infection and
▸Figure 1. Necroptosis during MCMV infection requires nucleic acid binding to the ZBDs of ZBP1.A, B Primary MEFs of the indicated genotypes were treated or not with 100 U/ml of IFN-A/D for 16 h. (A) Cell extracts were subjected to Western blot analysis using the
indicated antibodies. (B) Cells were treated with 30 ng/ml TNF and 20 lM zVAD (TZ) or were infected with the indicated viruses at an MOI of 10. After 16 h, cell
viability was assessed using CellTiter-Glo reagent. Values for untreated cells were set to 100%.
C Domain architecture of mouse ZBP1.
D Conservation of key amino acids in ZBP1’s ZBDs. ZBP1 sequences from the indicated species were aligned using Clustal Omega and the sequence context of the
conserved asparagine and tyrosine residues involved in Z-DNA/RNA binding is shown.
E HEK293T cells were transfected with 50 ng NF-jB firefly luciferase and 25 ng Renilla luciferase reporter plasmids, together with expression vectors for RIPK3
(0.2 ng) and HA-STING or ZBP1-3xFLAG (20, 100, 500 ng). Luciferase activity was measured after 24 h, and the ratio of firefly and Renilla luciferase was set to 1 for
control cells transfected with empty vector. Cell lysates were analysed for expression of the indicated proteins by Western blot (bottom). Asterisk (*) indicates
residual signal from the a-HA antibody.
F–I Immortalised Zbp1/ MEFs were reconstituted with the indicated ZBP1 mutants. (F) Cell extracts were subjected to Western blot analysis using the indicated
antibodies. (G and H) Cell viability upon TZ treatment or MCMV infection was assessed as in (B). In (G), an MOI of 10 was used. (I) Cell death was monitored upon
infection (MOI = 3) or TZ treatment using an in-incubator imaging platform (Incucyte) and the dye Sytox Green that stains dead cells.
Data information: Data are representative of three or more independent experiments. Panels (A, B, E and G–I) represent mean  SD (n = 3). **P < 0.01, ***P < 0.001;
two-way ANOVA. See also Fig EV1.
Source data are available online for this figure.
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behaved similar to the parental Zbp1/ cells, while ZBP1-Za1mut
and ZBP1-Za2mut cells showed intermediate phenotypes (Fig 1G and
H), with a greater contribution to cell death of the Za2 domain. Cell
death induced by MCMV-M45mutRHIM in wild-type ZBP1-expressing
cells was also observed by live-cell microscopy using the dye Sytox-
Green, which stains cells that have lost membrane integrity, and cell
death was detected from 8 h post-infection onwards (Fig 1I). We
then used mouse NIH3T3 fibroblasts, a transformed cell line.
Endogenous ZBP1 expression was undetectable by Western blot,
but could be induced by IFN treatment (Fig EV1D). We stably
transduced NIH3T3 cells to express either 3xFLAG-tagged wild-
type or mutant ZBP1 (Fig EV1D and F). Cell viability was compa-
rable between these cells after MCMV-M45wt infection (Fig EV1E)
and upon TZ treatment (Fig EV1G and H). Consistent with our
results in MEFs, cell viability was decreased in wild-type ZBP1 but
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Figure 2. ZBP1 restricts MCMV replication by inducing necroptosis but not IFN expression.
A Immortalised Zbp1/ MEFs reconstituted with wild-type or mutant ZBP1 were infected as indicated. After 5 days, cells were fixed and stained with crystal violet.
B Immortalised Zbp1/ MEFs reconstituted with wild-type or mutant ZBP1 were infected with MCMV-M45mutRHIM at an MOI of 0.01. DNA samples were collected at
0, 2, 4 or 6 days after infection and analysed by qPCR. gB copy numbers were derived from a titration using defined amounts of gB plasmid. The dotted line
represents the lower limit of detection.
C NIH3T3 cells reconstituted with wild-type or mutant ZBP1 were infected as indicated using an MOI of 3. After 0, 8 or 16 h, cell lysates were subjected to Western
blot analysis under reducing conditions using the indicated antibodies. The arrow indicates phosphorylated MLKL.
D NIH3T3 cells reconstituted with wild-type or mutant ZBP1 were infected with MCMV-M45mutRHIM at an MOI of 10. Cells were simultaneously treated with 3 lM
GSK’872 (RIPK3 inhibitor) or 30 lM Nec-1 (RIPK1 inhibitor) or 0.1% DMSO as a control. Cell viability was analysed 24 h after infection as in Fig 1B.
E Immortalised Zbp1/ MEFs reconstituted with wild-type or mutant ZBP1 were infected with MCMV-M45mutRHIM at an MOI of 3. RNA samples were collected 8 h
after infection and analysed by RT–qPCR.
F, G CXCL10 was analysed by ELISA in supernatants from MEFs of the indicated genotypes infected with MCMV-M45mutRHIM (MOI = 3; 8 h post-infection). The dotted
line represents the lower limit of detection.
Data information: Data are representative of two or more independent experiments. Panels (B and D–G) represent mean  SD (n = 3). *P < 0.05, ***P < 0.001; two-way
ANOVA. See also Fig EV2.
Source data are available online for this figure.
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MCMV-M45mutRHIM (Fig EV1E–H). Taken together, these observa-
tions suggest that induction of cell death by ZBP1 requires intact
ZBDs and may imply that nucleic acids in Z-conformation trigger
this response.
Nucleic acid recognition by ZBP1 is essential for necroptosis and
virus restriction, but not for IFN induction
We next wished to test whether restriction of MCMV infection by
ZBP1 depends on the protein’s ZBDs. Infection of cells with MCMV
results in lytic cell death after several days of culture due to virus
replication. Expression of wild-type ZBP1 but not ZBP1-Za1a2mut
protected Zbp1/ MEFs or NIH3T3 cells against MCMV-
M45mutRHIM-induced cytopathic effects 5 days post-infection
(Figs 2A and EV2A). Furthermore, replication of the virus genome
was blunted by wild-type but not by mutant ZBP1 (Fig 2B). These
observations show that ZBP1 defended cells against MCMV and that
intact ZBP1 ZBDs were required for this.
This block in virus replication may depend on ZBP1-dependent
cell death or engagement of an IFN response in infected cells. We
first explored how mutations in ZBP1’s ZBDs affected MCMV-
M45mutRHIM-induced cell death. Previous work suggested that the
type of cell death triggered by ZBP1 upon MCMV-M45mutRHIM infec-
tion is necroptosis (Upton et al, 2012). Upon phosphorylation by
RIPK3, MLKL forms trimers and large multimeric complexes, which
execute necroptosis by causing plasma membrane permeabilisation
(Wallach et al, 2016). Phosphorylation of MLKL was only observed
in MCMV-M45mutRHIM-infected NIH3T3 cells reconstituted with
wild-type ZBP1 and not in ZBP1-Za1a2mut ZBP1-expressing cells
(Fig 2C). Concomitantly, reduced levels of the viral IE1 protein
accumulated in cells expressing wild-type ZBP1 (Fig 2C). Further-
more, we observed the formation of MLKL-trimers (Cai et al, 2014)
in non-reducing SDS–PAGE gels after induction of necroptosis in
NIH3T3 cells with TZ (Fig EV2B). Large MLKL oligomers, which did
not migrate through the gel, were also observed in the gel-loading
pocket (Dondelinger et al, 2014; Fig EV2B). MCMV-M45wt infection
did not change MLKL electrophoretic mobility (Fig EV2B), which is
in line with our earlier observation that this virus does not cause
cell death (Fig 1). MCMV-M45mutRHIM infection induced MLKL
oligomerisation at 16 h post-infection (Figs 2C and EV2B). These
effects were enhanced and accelerated in cells expressing wild-type
ZBP1 but not in cells reconstituted with ZBP1-Za1a2mut (Fig EV2B).
Furthermore, the viability of MCMV-M45mutRHIM-infected NIH3T3
cells expressing wild-type ZBP1 was rescued upon treatment with
the RIPK3 kinase inhibitor GSK’872 (Fig 2D). As described previ-
ously (Upton et al, 2010), blocking RIPK1 activity with Nec-1 had
no effect on virus-induced cell death (Fig 2D). These observations
show that ZBP1 indeed activates necroptosis in this setting.
MCMV-M45mutRHIM infection also induced an IFN response.
Expression of the interferon-stimulated genes (ISGs) Ifit1, Ifi44 and
Oasl1 was increased upon infection and was not altered in cells
expressing ZBP1 (Fig 2E). Consistent with this observation, the
expression and secretion of CXCL10, a chemokine that signifies the
induction of an IFN response, were independent of ZBP1 or MCMV
M45 protein (Figs 2F and EV2C). Instead, CXCL10 induction was
reduced to background levels in Tmem173/ cells that lack STING,
a protein involved in cytosolic DNA sensing (Figs 2G and EV2C;
Chen et al, 2016). Furthermore, overexpression of ZBP1 did not
induce an IFNb reporter in HEK293T cells (Fig EV2D). In sum, these
results demonstrate that ZBP1 and its ZBDs were required specifi-
cally for the induction of necroptosis upon virus infection and not
for the induction of an IFN response.
ZBP1-Za1a2mut knock-in mice do not restrict MCMV-M45mutRHIM
and cells from these animals do not undergo virus-
triggered necroptosis
To substantiate our conclusion that intact ZBDs are required for
ZBP1-dependent necroptosis, we developed a knock-in mouse in
which the endogenous Zbp1 allele is replaced by Zbp1-Za1a2mut
(Zbp1Za1a2) carrying the four point mutations shown in Fig 1C. The
generation and validation of this model are detailed in Fig EV3A
and B. We obtained primary MEFs by crossing of Zbp1+/Za1a2
animals. Similar levels of Zbp1 mRNA and ZBP1 protein were
expressed at baseline and after IFN induction in cells expressing only
wild-type ZBP1 (Zbp1+/+), only mutant ZBP1 (Zbp1Za1a2/Za1a2) or
both (Zbp1+/Za1a2) (Figs 3A and EV3C). Consistent with our experi-
ments based on ectopic ZBP1 expression (Figs 1 and 2), intact ZBDs
of endogenous ZBP1 were required for cell death induced by
MCMV-M45mutRHIM (Fig 3B and C). Cell death induced by TZ treat-
ment was not affected by mutations in Zbp1 (Figs 3B and EV3D).
Furthermore, the levels of phosphorylated MLKL and MLKL
oligomerisation were reduced in Zbp1Za1a2/Za1a2 primary MEFs upon
MCMV-M45mutRHIM infection (Figs 3D and EV3E), but not after TZ
treatment (Fig 3E). Finally, virus growth and accumulation of the
viral IE1 protein were enhanced in Zbp1Za1a2/Za1a2 primary MEFs
(Fig 3D and F). To test whether intact ZBDs are required to restrict
virus replication in vivo, we infected Zbp1Za1a2/Za1a2 knock-in mice
with MCMV-M45mutRHIM. After 5 days, we were able to recover infec-
tious virus from the spleens of eight of 13 infected Zbp1Za1a2/Za1a2
animals, while the spleens of all wild-type and heterozygous mice
remained free of virus (Fig 3G). As expected, no differences in
splenic virus titres were observed between the genotypes when mice
were infected with wild-type MCMV (Fig 3G). These observations
provide further evidence that recognition of nucleic acids, poten-
tially in Z-conformation, by ZBP1 is required for the induction of
necroptosis and virus restriction.
MCMV-induced necroptosis requires viral RNA synthesis but not
DNA replication
To define the molecular requirements of ZBP1 and necroptosis acti-
vation in MCMV-infected cells, we co-cultured NIH3T3 cells
expressing wild-type and Za1a2mut ZBP1 at a 2:1 ratio. The latter
cells were labelled with a dye prior to co-culture. We infected
co-cultures with MCMV-M45wt or MCMV-M45mutRHIM and, after
16 h, determined the ratio of wild-type ZBP1 and ZBP1-Za1a2mut
cells by flow cytometry (Fig 4A). Infection with MCMV-M45wt did
not affect the ratio of these cells; however, MCMV-M45mutRHIM
infection resulted in selective loss of wild-type ZBP1-expressing cells
(Fig 4A). This observation shows that ZBP1-dependent cell death is
cell autonomous and further indicates that infection generates an
intracellular ZBP1 agonist, conceivably a nucleic acid in Z-confor-
mation.
To determine whether viral DNA replication was required for
ZBP1 activation, we treated infected cells with 50 lM of the
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Figure 3. Knock-in of ZBP1-Za1a2mut abrogates MCMV-triggered necroptosis.
A Primary MEFs of the indicated genotypes were treated or not with 100 U/ml of IFN-A/D for 16 h. Cell extracts were subjected to Western blot analysis using the
indicated antibodies. Asterisk (*) indicates a non-specific band.
B Primary MEFs of the indicated genotypes were treated or not with 100 U/ml of IFN-A/D for 16 h. Cells were treated with TZ or were infected with the indicated
viruses (WT MCMV: MOI = 3). After 24 h, cell viability was assessed using CellTitre-Glo reagent. Values for untreated control cells were set to 100%.
C Primary MEFs of the indicated genotypes were treated or not with 100 U/ml of IFN-A/D for 16 h. Cell death was monitored upon infection with MCMV-M45mutRHIM
(MOI = 3) using an in-incubator imaging platform (Incucyte) and the dye Sytox Green that stains dead cells.
D, E Primary MEFs of the indicated genotypes were treated or not with 100 U/ml of IFN-A/D for 16 h. Cells were infected with MCMV-M45mutRHIM at an MOI of 3 for 0,
8 and 16 h (D) or treated for 8 h with TZ (E), and cell lysates were analysed by Western blot.
F Primary MEFs of the indicated genotypes were treated or not with 100 U/ml of IFN-A/D for 16 h. DNA samples were collected at 0 and 4 days after infection and
analysed by qPCR. gB copy numbers were derived from a titration using defined amounts of gB plasmid.
G Za1a2-mutant Zbp1 knock-in (Zbp1Za1a2/Za1a2), heterozygous (Zbp1+/Za1a2) and wild-type (Zbp1+/+) littermate mice were infected with 2 × 106 pfu MCMV-M45WT
(one experiment) or MCMV-M45mutRHIM (pooled data from two experiments using independent virus stocks) by intraperitoneal injection. Five days post-infection
mice were sacrificed and viral titres in spleens were determined by plaque assay. Each dot represents one mouse. The dotted horizontal line depicts the detection
limit.
Data information: If not indicated otherwise, data are representative of two or more independent experiments. Panels (B, C, F and G) show mean  SD (n = 3 in B, C, F).
*P < 0.05, ***P < 0.001; two-way ANOVA (panels B, C and F) and Mann–Whitney t-test (panel G). See also Fig EV3.
Source data are available online for this figure.
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nucleotide analogue ganciclovir (Smee et al, 1995). Although this
effectively prevented MCMV replication in NIH3T3 cells and immor-
talised MEFs (Fig EV4A), virus-induced cell death in wild-type
ZBP1-reconstituted cells remained unaffected (Fig 4B). UV inactiva-
tion of MCMV-M45mutRHIM abrogated viral replication and expres-
sion of viral genes (Figs 4C, and EV4A and B). At the same time,
CXCL10 protein and ISG mRNA induction, which are dependent on
STING (Figs 2G and EV2C), remained normal (Figs 4C and EV4B).
Importantly, UV-treated MCMV did not induce cell death (Fig 4B).
Together with the result using the DNA replication inhibitor ganci-
clovir, this suggested that viral RNA transcription was required for
ZBP1-dependent necroptosis. Indeed, inhibition of de novo RNA
synthesis using actinomycin D (ActD) prevented cell death induced
by MCMV-M45mutRHIM in NIH3T3 cells expressing wild-type ZBP1
(Fig 4D). Similarly, ActD but not the translation inhibitor cyclohex-
imide (CHX) blocked MCMV-M45mutRHIM induced cell death in
primary MEFs (Fig 4E). We also interfered with expression of the
viral immediate early protein IE3 that is required for expression of
early and late genes (Angulo et al, 2000). siRNA-mediated depletion
of IE3 was confirmed using MCMV-IE1/3-GFP infection (Martı́nez
et al, 2010; Fig EV4C and D). IE3 depletion led to diminished cell
death upon infection of NIH3T3 cells expressing wild-type ZBP1
with MCMV-M45mutRHIM (Fig 4F). MCMV-M45mutRHIM infection
predisposes NIH3T3 cells to TNF-induced cell death independent of
ZBP1 expression (Fig EV4E). This predisposition is likely due to
expression of the MCMV protein M36, which blocks caspase-8 and
in combination with TNF treatment triggers necroptosis (Guo et al,
2015; Omoto et al, 2015). IE3 depletion did not influence cell death
triggered by MCMV-M45mutRHIM and TNF, indicating that IE3 deple-
tion did not change sensitisation to necroptosis (Fig EV4F). MCMV
induces a potent IFN response (Fig 2E and F), and IFN-induced
endogenous transcripts could contribute to ZBP1 activation. To test
this, we cultured wild-type ZBP1-reconstituted MEFs in the presence
of neutralising antibodies against the type I IFN receptor (anti-
IFNAR1). Blockade of IFNAR1 signalling did not affect MCMV-
M45mutRHIM-induced cell death, while the expression of the ISGs Ifit1
and Ifi44, but not of Ifnb, was reduced upon anti-IFNAR1 treatment
(Fig EV4G and H). Taken together, these data show that MCMV
RNA transcripts generated in infected cells contribute to the activa-
tion of ZBP1 and necroptosis.
To further substantiate this conclusion, we employed the PAR-
CLIP protocol (Fig 4G; Hafner et al, 2010). In brief, NIH3T3 cells
expressing ZBP1-3xFLAG were pulsed with photo-activatable
nucleoside analogues (4SU or 6SG) and were then infected with
MCMV-M45mutRHIM. Eight hours post-infection, cells were treated
with UV-A light (365 nm), which only cross-links newly synthesised
RNA that contains 4SU or 6SG to proteins. Cells were lysed and
treated with RNase A. In this setting, small fragments of RNA are
protected from degradation by cross-linking to proteins. ZBP1 was
then immunoprecipitated using a-FLAG antibody and stringent
conditions (see Materials and Methods). The RNA-ZBP1 complex
was visualised by 32P labelling of the RNA, followed by gel elec-
trophoresis, blotting and autoradiography (Fig 4G). Indeed, we
observed bands corresponding to the molecular weight of ZBP1
(60 kDa) when MCMV-infected cells were treated with 4SU or 6SG
(Fig 4G). To investigate whether cross-linking of newly synthetised
RNA required intact ZBDs, NIH3T3 cells expressing wild-type or
mutant ZBP1 were infected with MCMV-M45WT in the presence of
6SG. Wild-type M45-expressing virus was used to prevent loss of
wild-type ZBP1-expressing cells due to necroptosis. After cross-
linking, we observed enhanced ZBP1-RNA complex formation with
wild-type ZBP1 compared to mutant ZBP1, confirming that ZBDs
are important for RNA binding (Fig 4H). These finding supports the
notion that ZBP1 binds newly synthesised RNA in infected cells.
Ectopic expression of ZBP1 predisposes cells to necroptosis
Surprisingly, we observed that expression of ZBP1 in NIH3T3 cells
triggered spontaneous cell death upon caspase inhibition with zVAD
(Figs 5A and EV5A). zVAD had a similar, albeit less pronounced,
effect in immortalised MEFs (Fig 5A). Cell death in zVAD-treated
cells expressing ZBP1 required intact ZBDs (Figs 5A and EV5A).
Phosphorylation of MLKL at 16 h post-treatment confirmed that
cells died by necroptosis (Fig EV5B). Furthermore, treatment with
the RIPK3 inhibitor GSK’872 prevented cell death in zVAD-treated
cells (Fig 5B). Viability was also restored by Nec-1 treatment,
▸Figure 4. ZBP1 binds newly synthesised RNA in MCMV-infected cells.A NIH3T3 cells expressing mutant ZBP1 were labelled with CellTrace Violet and were then co-cultured with cells expressing wild-type ZBP1 at a 1:2 ratio. Cells were
then infected as indicated (MOI 1, 3 and 10) and analysed by flow cytometry after 16 h. Representative FACS histograms (MOI 3) are shown (left), and ratios of wild-
type to mutant cell numbers were calculated (right).
B Immortalised Zbp1/ MEFs were infected with MCMV-M45mutRHIM in the presence or not of 50 lM ganciclovir (GCV) or with UV-treated virus at an MOI of 10. After
16 h, cell viability was assessed using CellTitre-Glo reagent. Values for untreated control cells were set to 100%.
C Using supernatants and RNA samples from (B), CXCL10 protein levels and Ifi44 and M36 mRNA levels were determined by ELISA and RT–qPCR, respectively.
D Cell death was monitored upon infection of NIH3T3 cells expressing wild-type ZBP1 with MCMV-M45mutRHIM (MOI = 3) using an in-incubator imaging platform
(Incucyte) and the dye YOYO-3 that stains dead cells. Actinomycin D (ActD) was added (5 lg/ml) at the indicated time points.
E Primary MEFs of the indicated genotypes were pre-treated with 100 U/ml IFN-A/D for 16 h and were then treated with TZ, CHX (50 lg/ml) or ActD (5 lg/ml) in the
presence or absence of MCMV-M45mutRHIM. Cell viability was assessed as in (B).
F NIH3T3 cells expressing wild-type ZBP1 were transfected with the indicated siRNAs and were then infected with MCMV-M45mutRHIM. Cell viability was assessed as in
(D).
G Cells were treated with 100 lM 4SU or 6SG and infected with MCMV-M45mutRHIM for 8 h. Binding of newly synthesised RNA to ZBP1 was analysed by PAR-CLIP (see
Materials and Methods). Shown is an autoradiogram after electrophoresis and blotting of ZBP1 immunoprecipitates.
H NIH3T3 cells expressing wild-type or mutant ZBP1 were treated with 100 lM 6SG and were infected with MCMV-M45WT at an MOI of 3 for 8 h. Binding of ZBP1 to
RNA was analysed as in (G).
Data information: Data are representative of three or more independent experiments. Panels (A–F) show mean  SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001; two-
way ANOVA. See also Fig EV4.
Source data are available online for this figure.
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suggesting that spontaneous ZBP1-dependent cell death induced by
caspase inhibition additionally requires the activity of RIPK1
(Fig 5B).
Next, using a polyclonal cell population, we generated NIH3T3
clones expressing wild-type ZBP1 at different levels by limiting dilu-
tion (Figs 5C, and EV5C and D). Expression of ZBP1 at both low
and high levels sensitised cells to killing by MCMV-M45mutRHIM
(Fig 5D). In contrast, cell death triggered by ectopic ZBP1 and zVAD
required high levels of expression (Fig 5D). To further explore this
observation, we transduced cells expressing wild-type or Za1a2mut
ZBP1 with M36 that blocks caspase-8-mediated apoptosis. This led
to selective loss of cells expressing wild-type ZBP1 and M36
(Fig 5E). Western blot analysis further indicated that expression of
wild-type ZBP1 and M36 was mutually exclusive, indicating death
of cells expressing these two proteins together (Fig 5F). Taken
together, these observations suggested that cells contain endoge-
nous nucleic acids that engage ZBP1 if present at sufficiently high
levels. This then leads to necroptosis in conditions where caspase-8
activity is blocked.
ZBP1 binds endogenous RNA
To further explore the observation that ZBP1 triggers necroptosis in
response to endogenous nucleic acids, we used recombinant ZBP1
protein as a staining reagent in uninfected cells. We expressed
3xFLAG-tagged ZBP1 and ZBP1-Za1a2mut in HEK293T cells and
purified the proteins by immunoprecipitation (Fig EV6A). We then
incubated uninfected, fixed and permeabilised HEK293T cells with
purified ZBP1 protein, followed by staining with a secondary a-
FLAG antibody. Cells were analysed by flow cytometry. Recombi-
nant wild-type ZBP1 stained cells, whereas ZBP1-Za1a2mut showed
only background staining (Fig 6A, left panel). Interestingly, the
labelling of cells with wild-type ZBP1 was sensitive to RNase but
not to DNase treatment (Fig 6A, middle and right panel). These
observations suggest that ZBP1, via its ZBDs, binds endogenous
RNA, potentially in the Z-conformation.
Next, we used cross-link immunoprecipitation (CLIP, Fig 6B) to
further explore the binding of endogenous nucleic acids to ZBP1
(Darnell, 2010). In brief, we cross-linked nucleic acids and proteins
using UV-C light (254 nm) in uninfected NIH3T3 cells expressing
ectopic ZBP1-3xFLAG. Cell extracts were then treated with DNase
and/or RNase. This degrades free nucleic acids leaving intact frag-
ments of DNA or RNA cross-linked to proteins. Next, we immuno-
precipitated ZBP1 using a-FLAG antibodies (Fig EV6B). Nucleic
acids present in the precipitate were then end-labelled using 32P,
followed by Western blot and autoradiography (Fig 6B). Using high
amounts of RNase A, we observed a major band in the autoradio-
gram corresponding in size to ZBP1 (sample 3 in Fig 6B). In
samples without RNase A, this band was not visible; instead, a
smear of higher molecular weight was apparent (sample 1). These
patterns were not changed in samples containing DNase I (samples
2 and 4). These findings suggest that ZBP1 binds RNA and not
DNA. At the high RNase A concentrations used here, a very short
stretch of RNA is likely to be protected by ZBP1, explaining the
sharp band in lane 3 in Fig 6B. In the absence of RNase, this band
shifted to a slower migrating smear, indicating the presence of
longer RNA fragments bound to ZBP1. Indeed, when we used a
range of decreasing RNase A concentrations, we observed a
concomitant increase in the amount of 32P-labelled material migrat-
ing more slowly (Figs 6C and EV6C). Importantly, this shift was
markedly reduced when we used uninfected cells expressing ZBP1-
Za1a2mut despite equal efficiency of protein precipitation (Figs 6D
and EV6D). Taken together, these data show that ZBP1 binds
endogenous RNA but not DNA in uninfected cells.
Discussion
Mammalian cells autonomously detect virus infection (Pichlmair &
Reis e Sousa, 2007). Pattern recognition receptors (PRRs) sense
virus invasion and recognise pathogen- or danger-associated molec-
ular patterns (Medzhitov, 2009). Upon activation, these receptors
induce immune responses, including the production of cytokines
such as IFNs, chemokines and inflammatory mediators, as well as
the triggering of programmed cell death (Pichlmair & Reis e Sousa,
2007; Mocarski et al, 2012, 2015; Lupfer et al, 2015). In many
instances, nucleic acids such as viral RNA or DNA genomes trigger
PRRs (Goubau et al, 2013). This raises an important question: How
can PRRs distinguish between the RNAs and DNAs abundantly
found in healthy, uninfected cells and nucleic acids introduced
during infection? Several “solutions” to this problem have been
described and include detection of nucleic acids in cellular compart-
ments usually devoid of RNA or DNA, detection of covalent chemi-
cal modifications unique to viral RNAs and DNAs, and detection of
specific sequences (Goubau et al, 2013; Roers et al, 2016).
Here, we propose that RNA in the unusual Z-conformation is a
molecular pattern recognised by ZBP1. Indeed, we found that intact
ZBDs were required for ZBP1-dependent induction of necroptosis in
MCMV-infected cells. Several lines of evidence showed that ZBP1
recognises RNA, and not DNA, and that this RNA likely corresponds
to viral transcripts newly synthesised after infection. Firstly, the
induction of cell death could not be blocked by an inhibitor of the
viral DNA polymerase (GCV). Secondly, UV-inactivated virus that
failed to generate viral RNA transcripts also did not induce necrop-
tosis. Thirdly, necroptosis induction was sensitive to ActD, which
potently inhibits RNA transcription. Fourthly, knock-down of the
viral IE3 gene—that drives expression of many other viral genes—
reduced cell death. Lastly, PAR-CLIP analysis showed that ZBP1
cross-linked with newly synthesised RNA in infected cells.
Two recent studies published while this manuscript was in
preparation suggest that ZBP1 senses influenza A virus (IAV) infec-
tion and induces cell death of IAV-infected cells (Kuriakose et al,
2016; Thapa et al, 2016). Our results confirm these two reports in a
different infection model and resolve an important discordance:
Thapa et al reported that ZBP1 senses IAV RNA (Thapa et al, 2016)
while Kuriakose et al concluded that IAV proteins, particularly PB1
and NP, trigger ZBP1 (Kuriakose et al, 2016). Our results strongly
suggest that ZBP1 is an RNA sensor. We used stringent cross-link
and immunoprecipitation protocols and provide a detailed analysis
of ZBP1 mutants unable to bind Z nucleic acids, including a knock-
in model. It is conceivable that ZBP1 binds IAV PB1 and NP indi-
rectly via viral RNA as both IAV proteins tightly associate with IAV
RNA genomes and transcripts (Eisfeld et al, 2015). In the future, it
will be interesting to infect ZBP1-Za1a2mut knock-in mice with IAV
to analyse the role of Z-RNA sensing and necroptosis in in vivo
settings. Moreover, it will be worthwhile to explore other viral
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Figure 5. High levels of ectopic ZBP1 expression sensitise cells to necroptosis.
A NIH3T3 cells or immortalised Zbp1/ MEFs expressing wild-type or mutant ZBP1 were treated with 20 lM zVAD alone, 30 ng/ml TNF, or with TZ or were infected as
indicated (MOI = 10). Cell viability was assessed as in Fig 1B after 16 h.
B NIH3T3 cells reconstituted with wild-type or mutant ZBP1 were treated with 20 lM zVAD alone or TZ in combination with 3 lM GSK’872 (RIPK3 inhibitor) or 30 lM
Nec-1 (RIPK1 inhibitor) or 0.1% DMSO as a control. Cell viability was monitored after 24 h as in Fig 1B.
C Polyclonal and monoclonal NIH3T3 cell lines expressing no, low or high levels of ZBP1 were analysed by Western blot using the indicated antibodies. Asterisk (*)
indicates a non-specific band.
D Clonal cell lines from (C) were analysed as in (A).
E Zbp1/-immortalised MEFs expressing wild-type or mutant ZBP1 were transduced with empty or with M36 lentiviral vectors. Cell numbers were determined after
4 days.
F Cells from (E) were tested by Western blot using the indicated antibodies.
Data information: Data are representative of two or more independent experiments. Panels (A, B, D and E) show mean  SD (n = 3). *P < 0.05, ***P < 0.001; two-way
ANOVA. See also Fig EV5.
Source data are available online for this figure.
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infections. Indeed, necroptosis is also important during infection
with human cytomegalovirus (HCMV) and herpes simplex viruses
(HSV) 1 and 2 (Mocarski et al, 2015) and, in HIV-1 infection,
necroptosis of infected T cells may contribute to pathogenesis
(Gaiha et al, 2014; Pan et al, 2014).
Surprisingly, we found that cells expressing high levels of ZBP1
undergo necroptosis when caspase-8 is blocked and that ZBP1
cross-links to endogenous RNA in uninfected cells. This suggests a
model in which ZBP1 continuously senses self-RNA, but only
engages the necroptosis machinery when sufficient levels of
downstream signalling components such as RIPK3 become avail-
able, as is the case when caspase-8 is blocked. Indeed, loss of
caspase-8 activity predisposes to RIPK3-dependent necroptosis
(Kaiser et al, 2011; Oberst et al, 2011). Interestingly, ZBP1-depen-
dent cell death in this setting required the activity of both RIPK1
and RIPK3. This is in contrast to MCMV-induced necroptosis, which
occurs independently of RIPK1 (Upton et al, 2010). This may be
important during development and in sterile inflammation. RIPK1-
deficient mice display severe developmental defects and die around




Figure 6. ZBP1 binds endogenous RNA in uninfected cells.
A Fixed and permeabilised HEK293T cells were treated with DNase I or RNase A where indicated. Cells were then incubated with recombinant ZBP1-3xFLAG and were
subsequently stained with a-FLAG-APC antibody and analysed by flow cytometry. Histograms representing the APC signal are shown.
B An outline of the CLIP protocol is shown (left). NIH3T3 cells expressing wild-type ZBP1 were subjected to CLIP analysis using 20 U/ml DNase I and/or 20 U/ml RNase
A. ZBP1 associated nucleic acids were labelled with 32P and resolved by gel electrophoresis. The autoradiogram is shown (right).
C CLIP was performed as in (B) using different concentrations of RNase A. The autoradiogram shows supershifted RNA-ZBP1 complexes at intermediate RNase A
concentrations.
D CLIP analysis was done as in (B) and (C) using NIH3T3 cells expressing wild-type or mutant ZBP1.
Data information: For panels (B–D), sample numbers are indicated at the bottom of each lane. Data are representative of three or more independent experiments. See
also Fig EV6.
Source data are available online for this figure.
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inflammatory phenotypes (Silke et al, 2015). These observations
have been linked to excessive RIPK3-MLKL-driven necroptosis
(Silke et al, 2015). Two recent manuscripts showed that the defects
of germline or keratinocyte-specific RIPK1-deficient mice are
rescued by additional knock-out of ZBP1 (Lin et al, 2016; Newton
et al, 2016). It is tempting to speculate that ZBP1 engages an
endogenous Z-RNA in these settings and activates RIPK3 if inhibi-
tion by RIPK1 is lost. Our ZBP1-Za1a2mut knock-in model will be an
important tool to address this question.
It will also be interesting to extend our CLIP analysis by deep
sequencing of ZBP1-associated nucleic acids. It is possible that ZBP1
binds GC-rich sequences given that GC-rich nucleic acids adopt the
Z-conformation in the test tube under high salt conditions (Wang
et al, 1979; Hall et al, 1984). It is noteworthy that in cells Z-RNA
may not exist as a pre-formed structure but that this conformation is
induced upon binding of ZBP1 and other ZBD-containing proteins to
nucleic acids that are prone to adopt this structure, for example, due
to their sequence content (Kim et al, 2011a). We would also like to
point out that the RNA recognised by ZBP1 may correspond to both
double-stranded and single-stranded molecules. The former may be
the case in MCMV-infected cells, given that herpesviruses produce
overlapping transcripts from both DNA strands (Rajcáni et al, 2004;
Marcinowski et al, 2012; Juranic Lisnic et al, 2013). The latter may
be the case when endogenous RNA is sensed; for example, riboso-
mal RNAs fold back and form base-paired hairpin structures that
may be recognised by ZBDs (Feng et al, 2011).
Taken together, we demonstrate that binding of viral RNA to
ZBP1 triggers necroptosis in infected cells. Whether these RNA
molecules are indeed arranged in the Z-conformation requires
further experimental testing. Additionally, endogenous nucleic acids
may also adopt this unusual conformation and engage ZBP1. These
data indicate that Z-RNA may be molecular pattern and that ZBP1
functions as its receptor, which induces inflammatory cell death.
Materials and Methods
Mice
All mice were on the C57Bl/6 background. Tmem173/ (STING-
deficient) mice were a gift from J Cambier (Jin et al, 2011). The
Zbp1 gene is located on chromosome 2 (GenBank NM_021394.2;
Ensembl ENSMUSG00000027514). ZBP1-Za1a2mut transgenic mice
were generated by Cyagen (see Fig EV3A) and have been designated
as Zbp1 < tm1.1Jreh> (MGI:5775152). See Appendix Supplementary
Methods for further details. This work was performed in accordance
with the UK Animals (Scientific Procedures) Act 1986 and institu-
tional guidelines for animal care. This work was approved by a
project license granted by the UK Home Office (PPL No. 40/3583)
and was also approved by the Institutional Animal Ethics Committee
Review Board at the University of Oxford.
Cell culture
TLA HEK293T (Open Biosystems), NIH3T3 cells (kind gift from C.
Reis e Sousa), and immortalised MEFs (generated in this study)
were grown in DMEM (Sigma-Aldrich) supplemented with 10%
heat-inactivated FCS and 2 mM L-Gln. Cells were grown at 37°C and
5% CO2. Primary MEFs (kind gift from K. Ishii or generated in this
study) were grown in DMEM 10% FCS, 2 mM L-Gln, 100 U/ml peni-
cillin and 0.1 mg/ml streptomycin under low oxygen conditions
(3% O2) at 37°C and 5% CO2. The absence of mycoplasma contami-
nation was confirmed monthly for all cells.
Plasmids and reagents
Mouse Zbp1 was cloned from pCMV-SPORT6-Zbp1 (PlasmID clone:
MmCD00314236, Harvard Medical School). A 3xFLAG-tag was
added C-terminally to ZBP1 and TOPO-TA cloned into the pCR8/
GW/TOPO entry vector (ThermoFisher). Za1 (N46A, Y50A) and
Za2 (N122A, Y126A) mutant ZBP1 were cloned using overlap PCR.
MCMV M36 was cloned from cDNA isolated from MCMV-infected
NIH3T3 cells. ZBP1 and M36 were then Gateway cloned into pLen-
ti6.3/TO/V5-DEST or pcDNA3.2/V5-DEST using the LR clonase II
enzyme mix (ThermoFisher). The oligos used for cloning are listed
in Appendix Table S1. The plasmids for human MDA5 (pcDNA3-
3xFLAG-hMDA5), the IFNb firefly luciferase reporter (p125Luc) and
Renilla luciferase (Rluc) plasmids have been described before
(Rehwinkel et al, 2010). The mouse RIPK3 expression plasmid
(pCMV-SPORT6-mRIPK3) and the NF-jB firefly luciferase reporter
plasmid (pConLuc) were a gift from M. Bertrand and G. van Loo,
respectively. The expression vector for mouse STING (pcDNA3-HA-
mSTING) was a kind gift from R. Vance (Burdette et al, 2011).
pGEMTeasy-MCMV-gB was a kind gift from E. Beuken. IFN-A/D
was purchased from Sigma-Aldrich or R&D Systems. Recombinant
mouse TNF was from PeproTech. zVAD (Z-VAD-FMK) was from
Enzo Life Sciences. Actinomycin D was from Life Technologies and
CHX was from Sigma-Aldrich. Nec-1 was from Enzo Life Sciences,
and GSK’872 was from Calbiochem. Neutralising anti-IFNAR1
(clone MAR1-5A3) was from Biolegend.
Virus production and infection
MCMV-M45WT (K181 strain) and MCMV-M45mutRHIM were a kind
gift from E. Mocarski (Upton et al, 2010). MCMV was propagated in
NIH3T3 cells or immortalised Zbp1/ MEFs. See Appendix Supple-
mentary Methods for further details. Lentivirus for ZBP1 and M36
reconstitution was produced in TLA HEK293T cells using pLenti6.3/
TO/V5-DEST transducing vectors and the Virapower packaging mix
(ThermoFisher).
Cell viability assays
A total of 5,000 NIH3T3 cells or MEFs were seeded per well in 96-
well plates. Twenty-four hours later, cells were infected with MCMV
or treated with TNF and/or zVAD. Endpoint viability (generally
16 h post-infection/treatment) was determined by CellTiter-Glo
(Promega) using a luminometer (GloMax, Promega). For kinetic
analysis of cell death, an in-incubator imaging platform was used
(IncuCyte ZOOM, Essen Bioscience; 10× objective, 1 scan per well
in 96-well plates per hour; samples were imaged in triplicate wells).
To measure viability, the cell-impermeant dyes YOYO-3 Iodide
(0.25 lM) or Sytox Green (25 nM) (ThermoFisher) were added to
the medium prior to imaging. At the end of the experiment, cells in
control wells were lysed with 0.0625% Triton X-100 and total
number of dye-positive cells were set to 100%. For NIH3T3
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co-culture experiments, mutant ZBP1-expressing cells were labelled
with 5 lM CellTrace Violet (Molecular Probes) for 20 min at 37°C.
Cells were washed with medium and plated together with non-
labelled wild-type ZBP1-expressing cells in 24 wells. Cells were
then infected with MCMV. Sixteen hours post-infection, cells were
harvested and the ratio of labelled vs. non-labelled cells was
analysed by flow cytometry.
Luciferase reporter assays and CXCL10 ELISA
A total of 150,000 TLA HEK293T cells were seeded in 24-well plates.
Cells were transfected with NF-jB (50 ng) or IFNb firefly (125 ng)
and 25 ng of Renilla luciferase reporter constructs, and the indicated
amounts of expression vectors using FuGENE 6 (Promega). Luci-
ferase activity was measured 24 h after transfection using a lumi-
nometer (GloMax, Promega) and Dual-Glo reagents (Promega).
CXCL10 ELISA was from eBioscience.
qPCR and RT–qPCR
Cells were lysed in RLT buffer and homogenised using a Qiashred-
der (Qiagen), and RNA was purified using RNeasy columns with
DNase I digestion (Qiagen). cDNA synthesis was performed with
SuperScript II reverse transcriptase (Thermo Fisher) and oligo(dT)
primers (Ambion). For DNA extraction, cells were lysed in AL-buffer
and incubated with proteinase K at 56°C for 10 min, and DNA was
purified using DNeasy blood and tissue columns (Qiagen). 15 ng
DNA was amplified using TaqMan universal PCR (Applied Biosys-
tems) or EXPRESS SYBR GreenER (ThermoFisher) master mixes on
a 7,800 real-time PCR system (Applied Biosystems). mRNA expres-
sion data were normalised to GAPDH and analysed by the compara-
tive Ct method. A plasmid carrying a fragment of the MCMV gB
gene (pGEMTeasy-MCMV-gB) was used as a standard for determin-
ing the viral genome copy numbers (Vliegen et al, 2003). The lower
detection limit was 30 molecules. The qPCR probes and primers
used in this study are detailed in Appendix Table S2.
Western blot
Cells were lysed in 25 mM Tris.HCl pH 7.4, 150 mM NaCl, 2 mM
EDTA, 1% Igepal CA-630 (Sigma-Aldrich) and 5% glycerol, protease
inhibitors (Cell Signalling) and phosphatase inhibitor cocktail 3
(Sigma). Protein lysates were cleared by centrifugation at 16,000 g
for 10 min. Alternatively, cells were directly lysed in NuPAGE SDS–
PAGE sample loading buffer (ThermoFisher). 50 mM of the reduc-
ing agent DTT was added to the lysates, except for non-reducing
gels. Protein lysates were run on Bis-Tris SDS–PAGE gels (NuPAGE,
ThermoFisher). Primary antibodies used for Western blotting are
listed in Appendix Table S3. Anti-rabbit, anti-rat or anti-mouse
secondary antibodies coupled to HRP were from GE Healthcare.
Flow cytometry and fluorescence microscopy
For intracellular ZBP1 staining, cells were fixed and permeabilised
in Cytofix/Cytoperm (BD biosciences) according to manufacturer’s
instructions. When recombinant ZBP1 was used (Fig 6A), cells were
incubated with 0.3 lg ZBP1-3xFLAG for 1 h in Perm/Wash buffer.
In some instances, cells were pre-incubated for 30 min at 37°C with
30 U Purelink RNase A (Invitrogen) or Turbo DNase I (Ambion).
Anti-FLAG-APC (Abcam, clone M2) was used to detect ZBP1-FLAG.
Samples were analysed in FACS buffer (PBS, 2 mM EDTA, 1%
FCS). 1 lg/ml DAPI (Sigma-Aldrich) or Live/Dead Fixable Violet
(Molecular Probes) was used to exclude dead cells. Data were
acquired on Beckmann Coulter CyAn or BD Biosciences LSRFortessa
flow cytometers. FCS files were analysed using FlowJo V.10.0.8. For
fluorescence microscopy, polyclonal ZBP1-expressing NIH3T3 cells
were seeded on poly-D-lysine (Sigma-Aldrich)-coated coverslips
(Lab-Tek). Cells were fixed using 4% paraformaldehyde (Thermo-
Fisher) and blocked and permeabilised for 1 h in PBS + 5% BSA
(Sigma-Aldrich) + 0.1% saponin (Sigma-Aldrich). Primary antibody
(anti-FLAG-HRP, clone M2, Sigma-Aldrich) and detection antibodies
(anti-HRP-Alexa Fluor 594, Jackson Immunoresearch) were incu-
bated for 1 h in PBS + 5% BSA + 0.1% saponin (Sigma-Aldrich).
Images were acquired using a Zeiss Axiovert S100 inverted fluores-
cence microscope.
IE3 knockdown
siRNAs targeting MCMV IE3 were directed against exon 5 of the
IE1/3 gene and were designed using siDESIGN Center from Dharma-
con (GE Healthcare). siRNAs were ordered from Dharmacon, and
the sequences are detailed in Appendix Table S4. A total of 5,000
NIH3T3 cells were seeded per well in 96-well plates. 25 nM siRNAs
were transfected using DharmaFECT 1 (Dharmacon, GE Healthcare)
according to manufacturer’s instructions. One hour later, transfec-
tion mix was washed away, and cells were infected with MCMV.
(PAR)-CLIP
PAR-CLIP and CLIP protocols were adapted from (Hafner et al,
2010; Huppertz et al, 2014). Further details are provided in
Appendix Supplementary Methods.
ZBP1 purification
Wild-type and Za1a2mut mouse ZBP1 were purified based on the
protocol published in Sun et al (2013). See Appendix Supplementary
Methods for further details.
Statistics
Statistical analysis was performed in GraphPad Prism v7.00 as
detailed in the figure legends.
Expanded View for this article is available online.
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